These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
792 related articles for article (PubMed ID: 27998447)
1. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer]. Han W; Song YZ; He M; Li J; Zhang R; Qiao XY Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447 [No Abstract] [Full Text] [Related]
2. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy]. Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807 [TBL] [Abstract][Full Text] [Related]
3. The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement. Sawyer TE; Bonner JA; Gould PM; Foote RL; Deschamps C; Trastek VF; Pairolero PC; Allen MS; Shaw EG; Marks RS; Frytak S; Lange CM; Li H Cancer; 1997 Oct; 80(8):1399-408. PubMed ID: 9338463 [TBL] [Abstract][Full Text] [Related]
4. [Analysis of recurrence patterns after curative resection of stage IIIA-N2 non-small cell lung cancer]. Liu JW; Li J; Lin G; Shang XQ Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(33):2314-8. PubMed ID: 23158558 [TBL] [Abstract][Full Text] [Related]
5. Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target Volumes. Billiet C; De Ruysscher D; Peeters S; Decaluwé H; Vansteenkiste J; Dooms C; Deroose CM; De Leyn P; Hendrikx M; Bulens P; Le Péchoux C; Mebis J J Thorac Oncol; 2016 Sep; 11(9):1538-49. PubMed ID: 27374454 [TBL] [Abstract][Full Text] [Related]
6. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112 [TBL] [Abstract][Full Text] [Related]
8. [Postoperative survival analysis of patients with stage Ⅲ-pN2 non-small cell lung cancer]. Wu XW; Chen T; Yin S; Deng Y; Zhao B Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):782-786. PubMed ID: 30392344 [No Abstract] [Full Text] [Related]
9. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer. Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905 [TBL] [Abstract][Full Text] [Related]
10. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis. Wang S; Zhou W; Zhang H; Zhao M; Chen X Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223 [TBL] [Abstract][Full Text] [Related]
11. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved. Matsunaga T; Suzuki K; Takamochi K; Oh S Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998 [TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer]. Liu K; Chen HL; You QS; Huang JF; Wang H Ai Zheng; 2009 Jul; 28(7):725-9. PubMed ID: 19624899 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy. Isaka M; Kojima H; Takahashi S; Omae K; Ohde Y Lung Cancer; 2018 Jan; 115():28-33. PubMed ID: 29290258 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection. Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733 [TBL] [Abstract][Full Text] [Related]
15. Patterns of local-regional failure in completely resected stage IIIA(N2) non-small cell lung cancer cases: implications for postoperative radiation therapy clinical target volume design. Feng W; Fu XL; Cai XW; Yang HJ; Wu KL; Fan M; Xiang JQ; Zhang YW; Chen HQ Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1100-7. PubMed ID: 24529715 [TBL] [Abstract][Full Text] [Related]
16. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948 [TBL] [Abstract][Full Text] [Related]
17. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis. Kim BH; Kim HJ; Wu HG; Kang CH; Kim YT; Lee SH; Kim DW Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882 [TBL] [Abstract][Full Text] [Related]
18. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy. Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359 [TBL] [Abstract][Full Text] [Related]
19. [Analyses of risk factors for postoperative recurrence after curative resection of stage III A-N2 non-small cell lung cancer]. Qiang G; Guo Y; Xiao F; Yu Q; Liang C; Song Z; Tian Y; Shi B; Liu D Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(41):3239-43. PubMed ID: 25604225 [TBL] [Abstract][Full Text] [Related]
20. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer. Urban D; Bar J; Solomon B; Ball D J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]